U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Wed Apr 02 12:30:25 GMT 2025
Edited
by admin
on Wed Apr 02 12:30:25 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1|KAPPA
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
PT47RQF9HF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BGB-A445
Preferred Name English
Gimistotug
INN  
Official Name English
immunoglobulin G1-kappa, anti-[Homo sapiens TNFRSF4 (tumor necrosis factor receptor (TNFR) superfamily member 4, OX40, CD134)], humanized monoclonal antibody
Common Name English
BGBA445
Code English
gimistotug [INN]
Common Name English
H-gamma1 heavy chain humanized (1-450) [VH (Homo sapiens IGHV1-46*01 (84.7%) -(IGHD) -IGHJ4*01 (92.3%) L123>T (115), CDR-IMGT [8.8.13] (26-33.51-58.97-109)) (1-120) -Homo sapiens IGHG1*03v, G1m3>G1m17, nG1m1 CH1 K120, CH3 E12, M14 (CH1 R120>K (217) (121-
Common Name English
Code System Code Type Description
SMS_ID
300000054749
Created by admin on Wed Apr 02 12:30:25 GMT 2025 , Edited by admin on Wed Apr 02 12:30:25 GMT 2025
PRIMARY
CAS
2768487-95-0
Created by admin on Wed Apr 02 12:30:25 GMT 2025 , Edited by admin on Wed Apr 02 12:30:25 GMT 2025
PRIMARY
NCI_THESAURUS
C175453
Created by admin on Wed Apr 02 12:30:25 GMT 2025 , Edited by admin on Wed Apr 02 12:30:25 GMT 2025
PRIMARY
INN
12710
Created by admin on Wed Apr 02 12:30:25 GMT 2025 , Edited by admin on Wed Apr 02 12:30:25 GMT 2025
PRIMARY
FDA UNII
PT47RQF9HF
Created by admin on Wed Apr 02 12:30:25 GMT 2025 , Edited by admin on Wed Apr 02 12:30:25 GMT 2025
PRIMARY
From To
1_22 1_96
2_22 2_96
2_147 2_203
2_223 4_214
2_264 2_324
1_147 1_203
2_370 2_428
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
1_223 3_214
1_229 2_229
1_232 2_232
1_264 1_324
1_370 1_428
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_300
N 2_300
Related Record Type Details
TARGET -> AGONIST
IN-VITRO
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [1_1] [2_1] N-TERMINUS Amount: PIDOLIC ACID SZB83O1W42
AMINO ACID REMOVAL [1_450] [2_450] C-TERMINUS Amount: LYSINE K3Z4F929H6
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL